Seamus C. O'brien
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).
Journal: Antimicrobial agents and chemotherapy
Published: December 29, 2025
Expedited research and approval of medicines for drug-resistant bacterial infections in children.
Journal: Bulletin of the World Health Organization
Published: December 13, 2025
Evaluation of Drug-Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants.
Journal: Clinical and translational science
Published: November 28, 2025
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.
Journal: Lancet (London, England)
Published: June 09, 2025
Author Correction: Combining antibiotics to tackle antimicrobial resistance.
Journal: Nature microbiology
Published: April 09, 2025
Combining antibiotics to tackle antimicrobial resistance.
Journal: Nature microbiology
Published: March 27, 2025
Acinetobacter spp. in neonatal sepsis: an urgent global threat.
Journal: Frontiers in antibiotics
Published: June 12, 2024
US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 16, 2024
FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 16, 2024
Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii.
Journal: NPJ biofilms and microbiomes
Published: February 25, 2024
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries.
Journal: Nature communications
Published: November 27, 2023
Last Updated: 09/26/2026